The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis.

Autor: Shah R; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France. shahr@iarc.who.int., Hanna NM; Department of Surgery, Queen's University, Kingston, Ontario, Canada., Loo CE; Centre for Clinical Epidemiology, Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Selangor, Malaysia., David M; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.; School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland, Australia., Mafra A; Cancer Epidemiology and Prevention Team, Public Health Expertise, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.; Registre National du Cancer, Luxembourg Institute of Health, Strassen, Luxembourg., Fink H; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France., McFerran E; Queen's University Belfast, Belfast, UK., Garcia M; Cancer Screening Unit, Institut Català d'Oncologia (ICO), Early Detection of Cancer Group, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain., Ghodssighassemabadi R; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France., Acharya S; Assam Cancer Care Foundation, Assam, India.; PAY-W Clinic, Odisha, India., Niyibaga J; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France., Langselius O; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France., Frick C; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France., Lasebikan N; Oncology Center, University of Nigeria Teaching Hospital, Enugu, Nigeria., Vignat J; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France., Steinberg J; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia., Hughes S; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia., Kircher CE; Queen's University School of Nursing, Kingston, Ontario, Canada., Goldie CL; Queen's University School of Nursing, Kingston, Ontario, Canada., Egger S; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia., Sullivan R; King's College London, Institute of Cancer Policy, Guy's Hospital, London, UK., Ginsburg O; Center for Global Health, National Cancer Institute, Bethesda, MD, USA., Bray F; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France., Caruana M; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia., Hui H; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia., Ilbawi AM; Department of Non-Communicable Diseases, World Health Organization, Geneva, Switzerland., Canfell K; School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Soerjomataram I; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
Jazyk: angličtina
Zdroj: Nature cancer [Nat Cancer] 2025 Jan 02. Date of Electronic Publication: 2025 Jan 02.
DOI: 10.1038/s43018-024-00880-4
Abstrakt: The coronavirus disease 2019 pandemic substantially impacted the delivery of cancer services and programs. Here we reviewed and synthesized the global scale and impact of pandemic-related delays and disruptions on cancer services, including diagnosis, diagnostic procedures, screening, treatment and supportive and palliative care. Based on data from 245 articles in 46 countries, we observed declines in the number of cancer screening participation (39.0%), diagnoses (23.0%), diagnostic procedures (24.0%) and treatment (28.0%), ranging from a 15.0% decline for radiotherapy to a 35.0% decline for systemic treatment during the pandemic compared to during the prepandemic period. Medium-human development index (HDI) category countries experienced greater reductions than high- and very-high-HDI countries. Missing data from low-HDI countries emphasize the need for increased investments in cancer surveillance and research in these settings. PROSPERO registration: CRD42022301816.
Competing Interests: Competing interests: K.C. is co-principal investigator of an investigator-initiated trial of cervical screening, ‘Compass’, run by the VCS Foundation Australia, which is a government-funded not-for-profit charity. She is also co-principal investigator on a major implementation program ‘Elimination of Cervical Cancer in the Western Pacific’, which will receive support from the Minderoo Foundation and the Frazer Family Foundation and equipment donations from Cepheid. M.C. is an investigator on an investigator-initiated trial of cytology and primary human papillomavirus screening in Australia (Compass; ACTRN12613001207707 and NCT02328872 ), which is also conducted and funded by the VCS Foundation. The VCS Foundation has received equipment and a funding contribution for the Compass trial from Roche Molecular Systems and Ventana. However, K.C., M.C. and their institution on their behalf (the Daffodil Centre, a joint venture between Cancer Council NSW and The University of Sydney) do not receive direct funding from the industry for these or any other research project. The other authors declare no competing interests.
(© 2025. The Author(s), under exclusive licence to Springer Nature America, Inc.)
Databáze: MEDLINE
Externí odkaz: